Sleep-promoting action of the endogenous melatonin in schizophrenia compared to healthy controls

References

• Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 1997;12:657–65.
   PubMed Web of Science ®Google Scholar
• Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert, SM. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997;19:91–102.
   PubMed Web of Science ®Google Scholar
• Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994;17:638–45.
   PubMed Web of Science ®Google Scholar
• Fanget F, Claustrat B, Dalery J, Brun J, Terra JL, Marie-Cardine M, Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry 1989;25:499–501.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59: 22–33.
   PubMed Web of Science ®Google Scholar
• Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989;4:95–104.
   PubMed Web of Science ®Google Scholar
• Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663–7.
   PubMed Web of Science ®Google Scholar
• Chae KY, Kripke DF, Poceta JS, Shadan F, Jamil SM, Cronin JW, Kline LE. Evaluation of immobility time for sleep latency in actigraphy. Sleep Med 2009;10:621–5.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28: 193–213.
   PubMed Web of Science ®Google Scholar
• Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): Rationale and standardization. Br J Psychiatry 1989;155:59–65.
   Google Scholar
• Hughes RJ, Badia P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 1997;20:124–31.
   PubMed Web of Science ®Google Scholar
• Madjirova NP, Petrova NS, Delchev NK. Daily rhythmicity of temperature, pulse and blood pressure in schizophrenic patients. Schizophr Res 1995;14:183.
   PubMedGoogle Scholar
• Brunner P, Sözer-Topcular N, Jockers R, Ravid R, Angeloni D, Fraschini F, . Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur J Histochem 2006;50:311–16.
   PubMedGoogle Scholar
• Afonso P, Brissos S, Figueira ML, Paiva T. Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep. Schizophr Res 2010;120:227–8.
   PubMedGoogle Scholar
• Rao ML, Gross G, Strebel B, Halaris A, Huber G, Bräunig P, Marler M. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151–63.
   PubMed Web of Science ®Google Scholar
• Viganò D, Lissoni P, Rovelli F, Roselli MG, Malugani F, Gavazzeni C, . A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Neuro Endocrinol Lett 2000;22:137–41.
   Google Scholar
• Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005;9:11–24.
   PubMed Web of Science ®Google Scholar
• Cowen P, Plasma melatonin during desmethylimipramine treatment: Evidence for changes in noradrenergic transmission. Br J Clin Pharmacol 1985;19:799–805.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997;36:159–63.
   PubMedGoogle Scholar
• Pacchierotti C, Lapichino S, Bossini L, Pieraccini F, Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001;22:18–32.
   PubMed Web of Science ®Google Scholar
• Mann K, Rossbach W, Müller MJ, Müller-Siecheneder F, Pott T, Linde I, . Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology 2006;3:256–64.
   Google Scholar
• Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:237–41.
   PubMedGoogle Scholar
• Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N, Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000;61:373–7.
   PubMed Web of Science ®Google Scholar